| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.65B | — | +16.7% |
| Cost of Revenue | $362.6M | — | +20.2% |
| Gross Profit | $1.29B | — | +15.7% |
| R&D Expense | $263.3M | — | +3.4% |
| SG&A Expense | $522.2M | — | +12.1% |
| Operating Income | $477.6M | — | +21.0% |
| Pre-tax Income | $459.0M | — | +5.8% |
| Income Tax | $78.3M | — | +11.4% |
| Net Income | $380.7M | — | +6.3% |
| EPS (Basic) | $0.66 | — | +8.2% |
| EPS (Diluted) | $0.66 | — | +8.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.45B | -16.8% | -22.1% |
| Short-term Investments | $1.23B | -4.8% | +61.8% |
| Accounts Receivable | $775.7M | +17.6% | +15.9% |
| Inventory | $1.12B | -0.6% | +0.5% |
| Current Assets | $6.23B | -7.6% | +0.3% |
| Total Assets | $13.32B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $43.8M | — | -84.4% |
| Capital Expenditures | $64.9M | — | +15.9% |
| Investing Cash Flow | -$92.8M | — | -208.8% |
| Financing Cash Flow | -$451.2M | — | -74.9% |
| Free Cash Flow | -$21.1M | — | -109.4% |
| +2.3% |
| Current Liabilities | $1.41B | -22.3% | +1.0% |
| Long-term Debt | $598.5M | +0.0% | +0.1% |
| Total Liabilities | $2.99B | -10.9% | +5.8% |
| Stockholders' Equity | $10.33B | -0.1% | +2.0% |